+25.0%
FLEX vs MRNA
+945.0%
-920.1%
-52.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -12.3% | +13.1% | -25.4% | -12.3% |
| 7D | -17.0% | +20.6% | -37.6% | -17.0% |
| 30D | -33.8% | +27.1% | -61.0% | -33.8% |
| 3M | -39.0% | +353.4% | -392.4% | -38.9% |
| 6M | -15.9% | +446.3% | -462.2% | -21.5% |
| YTD | +27.8% | +776.2% | -748.3% | +4.5% |
| 1Y | +25.0% | +987.9% | -963.0% | -7.3% |
| All | +25.0% | +945.0% | -920.1% | -7.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling